Applying Implementation Science in the Field of Transplant and Cellular Therapy
- PMID: 38909780
- PMCID: PMC11748216
- DOI: 10.1016/j.jtct.2024.06.018
Applying Implementation Science in the Field of Transplant and Cellular Therapy
Abstract
Implementation science (IS) is a systematic way to approach the broader adoption of evidence-based practices and has as its goal to understand and address the gap between research and practice, ensuring that research findings are effectively translated into practice and policy to improve health outcomes and service. We describe the various facets of IS and their relevance to the field of hematopoietic cell transplantation and cellular therapy (HCT/CT) with an emphasis on health equity, community engagement, and systems approach. We also review the similarities and differences among clinical research, quality improvement, and IS. Additionally, we describe how the Center for International Blood and Marrow Transplant Research applies IS across various phases: dissemination, analyzing current practices, and developing implementation intervention strategies. This includes designing studies and evaluations, scaling up operations, and ensuring sustainability. Lastly, we discuss further applications of IS in HCT/CT including the application to prospective research studies, collaboration across the field, and standardization and adoption of best practices. The application of IS in HCT/CT is pivotal to bringing research benefits directly to all patients. Through partnership, open-mindedness, and a commitment to evidence-based practice, we can collectively ensure the greatest impact of research on improving patient outcomes following HCT/CT.
Keywords: Cell therapy; Clinical research; Evidence-based practice; Hematopoietic cell transplant; Implementation science; Outcomes; Quality improvement.
Copyright © 2024 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Interest: None relevant to this work
Figures
References
-
- Khera N, Mau LW, Denzen EM, Meyer C, Houg K, Lee SJ, Horowitz MM, Burns LJ. Translation of clinical research into practice: an impact assessment of the results from the Blood and Marrow Transplant Clinical Trials Network Protocol 0201 on Unrelated Graft Source Utilization. Biology of Blood and Marrow Transplantation. 2018. Nov 1;24(11):2204–10. - PMC - PubMed
-
- Bolon YT, Atshan R, Allbee-Johnson M, Estrada-Merly N, Lee SJ. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR summary slides, 2022.
-
- Weiner BJ, Lewis CC, Sherr K, editors. Practical implementation science: moving evidence into action. Springer Publishing Company; 2022. Mar 18.
Publication types
MeSH terms
Grants and funding
- R01 AI158861/AI/NIAID NIH HHS/United States
- R01 CA231838/CA/NCI NIH HHS/United States
- U01 AI126612/AI/NIAID NIH HHS/United States
- R21 AG077024/AG/NIA NIH HHS/United States
- U24 HL157560/HL/NHLBI NIH HHS/United States
- R01 HL155741/HL/NHLBI NIH HHS/United States
- C0000008/CL/CLC NIH HHS/United States
- OT3 HL147741/HL/NHLBI NIH HHS/United States
- 27307C0011/ES/NIEHS NIH HHS/United States
- R01 CA100019/CA/NCI NIH HHS/United States
- R01 AI150999/AI/NIAID NIH HHS/United States
- 27398C0011/ES/NIEHS NIH HHS/United States
- P01 CA111412/CA/NCI NIH HHS/United States
- 27307C0009/ES/NIEHS NIH HHS/United States
- R01 AI128775/AI/NIAID NIH HHS/United States
- U24 CA076518/CA/NCI NIH HHS/United States
- U24 HL138660/HL/NHLBI NIH HHS/United States
- U01 AI069197/AI/NIAID NIH HHS/United States
- R01 CA231141/CA/NCI NIH HHS/United States
- UG1 HL069254/HL/NHLBI NIH HHS/United States
- R01 CA218285/CA/NCI NIH HHS/United States
- R01 CA262899/CA/NCI NIH HHS/United States
- 27305C0011/ES/NIEHS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Miscellaneous
